tradingkey.logo

Pelthos Therapeutics Ord Shs

PTHS
26.015USD
+3.345+14.76%
Close 12/19, 16:00ETQuotes delayed by 15 min
80.41MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of Pelthos Therapeutics Ord Shs to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---15.26M
Net income from continuing operations
---16.24M
Operating gains losses
--1.07M
Other non-cash items
--866.11K
Change in working capital
---5.03M
-Change in receivables
---7.94M
-Change in inventory
--1.39M
-Change in prepaid expenses
---1.46M
-Change in payables and accrued expense
---3.10M
-Change in other current assets
--243.00K
-Change in other current liabilities
---759.00K
Cash from non-recurring investing activities
Cash from operating activities
---15.26M
Investing cash flow
Net cash flow from business transactions
--2.76M
Cash from non-current investing activities
Net cash flow from investing activities
--2.76M
Financing cash flow
Cash flow from continuous financing activities
--26.69M
Net cash flow from debt Issuance/repayment
--26.61M
Net cash flow from common stock issuance/repurchase
--0.00
Proceeds from stock option exercised by employees
--85.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
--26.69M
Net cash flow
Beginning cash balance
--0.00
Current period cash flow changes
--14.19M
Ending cash balance
--14.19M
Free cash flow
---15.26M
Currency unit
USD
Audit opinions
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI